Our Research

Discover the cutting-edge research happening across our Institute

Research activities

 

Our research is driven by our innovative research groups who cover a wide range of topics and interests.  Our PhD programme and ECR training support the development of researchers, while our Core Facilities provide infrastructure and expertise across a wide range of research areas.

Research Groups

PhD Programme

Core Facilities

Research Areas

Our Research Group Leaders

 

Head shot photograph of Professor Samra Turajlić
Samra Turajlić

Director & Senior Group Leader

iD
Claus Jørgensen Deputy Director & Senior Group Leader
Claus Jørgensen

Deputy Director & Senior Group Leader

iD
Dr Amaya Viros
Amaya Virós

Institute Fellow

iD
Photo of Tim Somervaille
Tim Somervaille

Senior Group Leader

iD
Caroline Dive Director & Senior Group Leader
Caroline Dive

Senior Group Leader

iD
Photo of Group Leader Santiago Zelanay
Santiago Zelenay

Senior Group Leader

iD
Portrait photograph of Dr Evangelos Giampazolias in the Paterson Building reception
Evangelos Giampazolias

Group Leader

iD
Georges Lacaud

Senior Group Leader

iD
Iain Hagan

Senior Group Leader

iD
Head shot of Mark Williams
Mark Williams

Institute Fellow

iD
Rob Bristow

Senior Group Leader

iD
Kathryn Simpson

Team Lead

iD
Photo of Junior Group Leader Sylvain Delaunay
Sylvain Delaunay

Group Leader

iD
Photograph of Dr William Hill
William Hill

Institute Fellow

Headshot photo of Institute Fellow Justin Loke
Justin Loke

Institute Fellow

iD

Get in touch

Gloved hands filling a stripette white lab coat

Latest from CRUK MI

Cancer Research In the Paterson Building

Find out more about the facilities across the Institute

Services and Support

Leukaemia Immunology & Transplantation

The Leukaemia Immunology and Transplantation laboratory aim to develop a comprehensive strategy to prevent post-transplant relapse in patients treated with allogeneic haematopoietic stem cell transplantation – the only curative therapy for many patients with acute myeloid leukaemia (AML) and other poor-risk haematological malignancies.

Read more

Patient derived preclinical models reveal novel biology of SCLC

Immune detection of dying tumour cells can elicit cancer immunity when the host permits it

Read more
Cancer Research In the Paterson Building
Leukaemia Immunology & Transplantation
Patient derived preclinical models reveal novel biology of SCLC
Read all latest